10:52 AM EST, 11/21/2024 (MT Newswires) -- Biomerica ( BMRA ) said Thursday it received three international patents covering the technology and methods for treating gastroesophageal reflux disease, Crohn's disease, and ulcerative colitis using its inFoods technology.

The patents cover countries under the European Patent Organization, including the UK, Germany, France, Italy, and Spain, the company said.

Biomerica ( BMRA ) shares were up 4% in recent trading.

Price: 0.33, Change: +0.01, Percent Change: +4.06